Related Experiment Videos
Chemokine-based therapies for MS: how do we get there from here?
P Kivisäkk1, C Trebst, D J Eckstein
1Dept of Neurosciences, The Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Trends in Immunology
|November 8, 2001
Summary
This workshop explored chemokines and their role in multiple sclerosis (MS). It focused on potential therapeutic and prophylactic interventions for MS, a chronic neurological disease.
Area of Science:
- Neuroimmunology
- Molecular Biology
Background:
- Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- Chemokines are signaling proteins crucial in immune cell trafficking and inflammation.
- Understanding chemokine roles in MS pathogenesis is vital for developing new treatments.
Framework:
- The workshop convened experts to discuss the latest research on chemokines in MS.
- Key themes included chemokine receptor interactions and their impact on immune cell infiltration into the CNS.
- Discussions focused on identifying therapeutic targets within chemokine pathways.
Implementation:
- Held in Chevy Chase, MD, USA, on July 9-10, 2001.
- Facilitated exchange of data and ideas among leading researchers.
- Aimed to foster collaborative efforts in MS research.
Implications:
- Potential for novel therapeutic strategies targeting chemokine pathways in MS.
- Exploration of prophylactic interventions to prevent or slow MS progression.
- Advancement of knowledge in neuroinflammation and autoimmune disease mechanisms.